Insights from artificial intelligence could eventually transform drug development, if the quality and quantity of biological and chemical data can be improved.
1. Standardize reporting and methods
2. Recognize the value of negative results
3. Share industry data and expertise
4.Share industry data and expertise
- doi: https://doi.org/10.1038/d41586-025-00602-5
